SANUWAVE Health Inc. (SNWV)
NASDAQ: SNWVHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SNWV stock chart
Technical analysisKey statistics
All statistics- Market cap
- $12.90M
- EPS (TTM)
- -$0.38
- Dividend yield
- None
- 52-week range
- 1.48 – 35.29
- Day range
- 1.48 – 1.59
- Volume / Avg
- 57.70K / 78.45K
- Beta
- —
- Shares outstanding
- 8.60M
52-week range
SNWV stock today
SANUWAVE Health (SNWV) closed at $1.50 on Nov 20, down 5.66% (-$0.09), versus the S&P 500's 3.70% decline. At this level, SNWV sits near the bottom of its 52-week range of $1.48 to $35.29: 95.7% below the high, set on Nov 26, 2025 and 1.4% above the low. SNWV is down 95.0% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 95.5%.
SANUWAVE Health has posted a net loss over the last twelve months (EPS of -$0.38), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About SANUWAVE Health
Company profileSANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Morgan C. Frank
- Headquarters
- Eden Prairie, MN
- Employees
- 55
- Website
- sanuwave.com
Financial highlights
Full financialsIn fiscal 2025, SANUWAVE Health generated $44.1 million in revenue, up 35.0% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $11.8 million, for a net margin of 26.8% versus a median of -126.5% in the prior 5 years. Gross margin was 77.1% (up from 75.2%) and operating margin 11.2%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $44.05M | $32.63M | $20.40M | $16.74M | $13.01M |
| Growth | +34.98% | +59.99% | +21.84% | +28.69% | +220.68% |
| Net income | $11.81M | $-33.08M | $-25.81M | $-10.29M | $-27.26M |
| EPS (diluted) | $0.41 | $-7.41 | $-12.19 | $-0.02 | $-0.05 |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 10, 2026
- EPS actual vs est.
- $0.46 vs —
SNWV news
All SNWV news- SANUWAVE Health (SNWV) Q3 2026 Earnings Call TranscriptNasdaqSNWV, BIO.B
- Sanuwave Announces Q3 FY2026 Financial ResultsGlobeNewswire
- Sanuwave Will Host a Conference Call on November 11, 2026 at 8:30 AM (ET) to Present Q3 2026 Financial ResultsGlobeNewswire
- Sanuwave Health Comments on 2027 Medicare Physician Fee Schedule Rate for UltramistGlobeNewswire
- SANUWAVE Health, Inc. Enters Credit Agreement Amendment and Waiver, Agrees to Pay $5,000 FeeNasdaq
SANUWAVE Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CTSOCytosorbents Corporation | 4.16 | -18.91% | $13.12M | vs SNWV |
| CVRXCVRx Inc. | 0.501 | -5.99% | $14.27M | vs SNWV |
| DRIODarioHealth Corp. | 1.32 | -8.33% | $14.90M | vs SNWV |
| GUTSFractyl Health Inc. | 0.82 | -14.16% | $10.88M | vs SNWV |
| FEMYFemasys Inc. | 1.24 | 0.00% | $10.73M | vs SNWV |
| MODDModular Medical Inc. | 1.68 | -11.81% | $16.36M | vs SNWV |
| RVPRetractable Technologies Inc. | 0.558 | -6.84% | $16.70M | vs SNWV |
| PAVMPAVmed Inc. | 1.14 | -5.42% | $9.08M | vs SNWV |
Indexes, lists and sector
SANUWAVE Health stock FAQ
What is SANUWAVE Health's stock price today?
SNWV last traded at $1.50 as of Nov 20, 4:00 PM EST, down 5.66% on the day. Prices are delayed at least 15 minutes.
Who is SANUWAVE Health's CEO?
Mr. Morgan C. Frank is the chief executive officer of SANUWAVE Health Inc., which has about 55 employees.
What is the SNWV 52-week high?
The 52-week high for SNWV is $35.29 and the 52-week low is $1.48. The stock is currently 95.7% below its high.